In gastric cancer, GLI2 has been identified as an intrinsic regulator of programmed cell death ligand 1 (PD-L1) expression in tumor cells that promote tumor growth by inhibiting the anti-tumor response [37]. This evidence concerns the gene GLI2 and neoplasm.